Pain Medications: Lifesaving Tools Under Political Fire – How California Physicians Can Protect Their Licenses

Pain medications, particularly opioids and other controlled substances, are essential in modern medicine. They relieve acute suffering after surgery or injury, promote healing by allowing patients to participate in physical therapy and daily activities, and enable millions of Americans with chronic pain to maintain functional, productive lives. For patients with intractable pain, cancer-related pain, or long-term conditions that do not respond to non-opioid alternatives, these medications are often not just helpful — they are critical.

Yet in recent years, politics has heavily influenced the practice of pain management. The national opioid crisis has led to heightened scrutiny from regulators, including the Medical Board of California (MBC), the Drug Enforcement Administration (DEA), and state pharmacy boards. Well-intentioned efforts to combat misuse and diversion have created a climate where diligent physicians who prescribe appropriately can still face aggressive investigations, accusations of excessive prescribing, or even threats to their medical licenses.

Why Physicians Face Increased Risk When Prescribing Pain Medications

Even when you follow best medical practices, several external factors can trigger scrutiny:

• Pharmacies may flag and report high-volume prescribers or unusual patterns through the CURES (Controlled Substance Utilization Review and Evaluation System) database.
• Disgruntled employees, former staff, or patients can file complaints with the Medical Board, sometimes motivated by personal grievances rather than legitimate concerns.
• Competitors or rival practices may report you as a way to undermine your practice.
• Automatic data triggers from prescription monitoring programs, overdose deaths (even if remotely linked), or high-dose/long-term opioid prescriptions can prompt retrospective reviews.

Once a complaint is filed, the Medical Board often begins an investigation by requesting patient records. Investigators evaluate whether your prescribing meets the standard of care in your community — frequently comparing you to pain management specialists. Failure to document thoroughly can make even appropriate care look suspicious.

Under California Business and Professions Code Section 725, repeated acts of clearly excessive prescribing can constitute unprofessional conduct, potentially leading to probation, license suspension, or revocation. Related statutes address prescribing without adequate examination or to known addicts. The stakes are high: investigations are not truly “informal,” and an accusation can follow if the Board believes violations occurred.

The MBC’s Guidelines for Prescribing Controlled Substances for Pain emphasize individualized care, thorough documentation, risk assessment, and ongoing monitoring — but they are not rigid laws. Deviations can be appropriate when clinically justified, provided you document your rationale clearly.

What Strong Documentation and Procedures Look Like

Your medical records and office protocols are often the decisive factor between a quick resolution and serious disciplinary action. Key protective elements include:

• Comprehensive initial evaluation: Detailed history of the pain condition, prior treatments, diagnostic studies, functional impact, and risk factors for misuse or addiction.
• Treatment plan: Clear goals for pain relief and improved function, discussion of risks and benefits, and consideration of non-opioid alternatives where appropriate. The guidelines stress that opioids should be used when benefits are expected to outweigh risks, without forcing patients to “fail” multiple therapies first.
• Informed consent and pain management agreements: Written agreements covering patient responsibilities, single prescriber/pharmacy rules, urine drug screening (UDT), and secure storage of medications.
• CURES checks: Review the Patient Activity Report before initiating controlled substances and periodically thereafter (required within 24 hours for the first prescription in many cases, with ongoing checks recommended every 3–6 months).
• Periodic monitoring: Regular follow-ups, urine drug tests, pill counts when indicated, and documentation of any aberrancies along with your clinical response.
• Rationale for decisions: Explicit notes explaining why a particular dose, duration, or continuation of therapy is medically appropriate, especially for long-term or higher-dose regimens.
• Coordination of care: Notes on referrals to specialists, physical therapy, or addiction medicine when relevant.

Thorough, contemporaneous documentation proves that your decisions were based on sound clinical judgment rather than negligence or diversion. Peer reviewers and investigators rely heavily on what is written in the chart. If it isn’t documented, it can be difficult to defend.

Additional safeguards include staying current with mandatory CME on pain management and opioid-dependent patients, offering naloxone when appropriate, and having clear office policies for handling refills, early requests, or non-compliant patients.

Politics, Guidelines, and the Real-World Pressure on Physicians

California has updated its pain prescribing guidelines in recent years to better balance patient needs with public safety. The current version reinforces that guidelines are not inflexible standards and should not override a physician’s individualized judgment. Yet the regulatory environment remains challenging. Data-driven reviews, mandatory CURES queries, and heightened awareness of overdose risks mean that pain management physicians — and any doctor who regularly prescribes controlled substances — operate under a microscope.

Undertreatment of legitimate pain is also a serious concern. Patients who lose access to effective medications can suffer greatly, sometimes turning to illicit sources with far higher risks.

Protect Yourself Before an Investigation Begins

The best defense is proactive risk management: excellent patient care paired with bulletproof documentation and procedures. However, if you receive a letter from the Medical Board, a pharmacy report, or learn of a complaint, do not attempt to handle it alone. Early intervention with experienced counsel can often resolve matters favorably or limit their scope.

The physician lawyers at Lawyers in Lafayette specialize in defending California doctors in Medical Board investigations, accusations, peer review proceedings, and related licensing matters. Led by Daniel Horowitz, a certified criminal defense specialist, former law professor, and veteran trial lawyer with extensive experience in physician defense, the team includes a licensed medical doctor who is also an attorney. They understand both the medicine and the law.  Call for an initial consultation at (925) 283-1863